Epidermolysis bullosa (EB) is the term given to a group ... These variants as well as Dowling-Meara (the most severe type of EBS) and mottled pigmentation variants are caused by mutations in ...

DEBRA Research and LEO Pharma enter strategic partnership to advance treatments for rare skin diseases: Munich, Germany Thursday, February 6, 2025, 10:00 Hrs [IST] DEBRA Research ...

LEO Pharma and non-profit organisation DEBRA Research have announced a collaboration aimed at accelerating the development of treatments for epidermolysis bullosa (EB). The non-exclusive strategic ...

Epidermolysis Bullosa (EB), or butterfly disease, affects 1 in 50,000 people, causing fragile skin that blisters easily, often likened to the delicacy of butterfly wings.

Long-term treatment with Oleogel-S10 was well tolerated in patients with epidermolysis bullosa, in the 24-month open-label phase of a phase 3 study.

its drug for rare and debilitating skin disease epidermolysis bullosa (EB). Shares in the Ireland-based rare disease specialist fell sharply after news of the complete response letter (CRL ...

Jeremiah Marshall, a 33-year-old man from San Diego, California, suffers from one of the world's rarest conditions, epidermolysis bullosa, which makes his skin so delicate that even a slight touch ...

DEB is one of the more severe forms of the epidermolysis bullosa (EB) group – sometimes referred to as “the worst disease you have never heard of”. In severe cases, it can lead to internal ...

Research into new bandaging aims to ease the agony experienced by those living with genetic skin condition Epidermolysis Bullosa (EB ... which can cause severe pain when applied and removed.